Wilson Marc
CFO at CRNX
- Sold, on record
- $6.6M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Sep 26, 2024
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CRNXCrinetics Pharmaceuticals, Inc.CFO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CRNXRoutineJan 2 2024
Sold 10,000 shares at $35.47 ($355k)
Wilson Marc, CFO
10b5-1 planSold 9.4% of holdings ($3.8M position)96,055 shares leftFollows a Form 144Filing
- 2 Form 144 notice CRNXNoticeMar 19 +77 days
Filed to sell 6,942 shares ($298k)
Wilson Marc, Officer
10b5-1 plan0.7x usual sizeFiling
- 3 Form 4 sale CRNXRoutineMar 19 same day
Sold 6,942 shares at $42.91 ($298k)
Wilson Marc, CFO
10b5-1 planSold 5.9% of holdings ($5M position)110,630 shares left0.7x usual sizeFollows a Form 144Filing
- 4 Form 144 notice CRNXNoticeJun 28 +101 days
Filed to sell 32,129 shares ($1.4M)
Wilson Marc, Officer
10b5-1 plan3.2x usual sizeFiling
- 5 Form 4 sale CRNXUnusualJun 28 same day
Sold 32,129 shares at $43.61 ($1.4M)
Wilson Marc, CFO
10b5-1 planSold 22.4% of holdings ($6.2M position)111,092 shares left3.2x usual sizeFiling
- 6 Form 4 sale CRNXRoutineJul 15 +17 days
Sold 25,000 shares at $55.00 ($1.4M)
Wilson Marc, CFO
10b5-1 planSold 18.4% of holdings ($7.5M position)111,092 shares left2.5x usual sizeFiling
- 7 Form 4 sale CRNXRoutineJul 25 +10 days
Sold 19,056 shares at $53.88 ($1M)
Wilson Marc, CFO
10b5-1 planSold 14.6% of holdings ($7M position)111,092 shares left1.1x usual sizeFiling
- 8 Form 4 sale CRNXRoutineSep 26 +63 days
Sold 25,000 shares at $51.11 ($1.3M)
Wilson Marc, CFO
10b5-1 planSold 18.4% of holdings ($7M position)111,092 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | CRNX | CFO | Form 4 sale | 25,000 | $1.3M | 18.4% | Routine | SEC |
| Jul 25, 2024 | CRNX | CFO | Form 4 sale | 19,056 | $1M | 14.6% | Routine | SEC |
| Jul 15, 2024 | CRNX | CFO | Form 4 sale | 25,000 | $1.4M | 18.4% | Routine | SEC |
| Jun 28, 2024 | CRNX | CFO | Form 4 sale | 32,129 | $1.4M | 22.4% | Unusual | SEC |
| Jun 28, 2024 | CRNX | Officer | Form 144 notice | 32,129 | $1.4M | Notice | SEC | |
| Mar 19, 2024 | CRNX | CFO | Form 4 sale | 6,942 | $298k | 5.9% | Routine | SEC |
| Mar 19, 2024 | CRNX | Officer | Form 144 notice | 6,942 | $298k | Notice | SEC | |
| Jan 2, 2024 | CRNX | CFO | Form 4 sale | 10,000 | $355k | 9.4% | Routine | SEC |
| Jan 2, 2024 | CRNX | Officer | Form 144 notice | 10,000 | $355k | Notice | SEC | |
| Nov 1, 2023 | CRNX | CFO | Form 4 sale | 10,000 | $288k | 9.5% | Routine | SEC |
| Nov 1, 2023 | CRNX | Officer | Form 144 notice | 10,000 | $287k | Notice | SEC | |
| Jun 20, 2023 | CRNX | CFO | Form 4 sale | 30,922 | $617k | 24.5% | Routine | SEC |
| Jun 20, 2023 | CRNX | Officer | Form 144 notice | 30,922 | $617k | Notice | SEC |